Education
About Us
Working with TipRanks
Follow Us
Sinopharm Tech Holdings Limited (HK:8156)
:8156
Total Valuation
Sinopharm Tech Holdings Limited has a market cap or net worth of HK$199.61M. The enterprise value is ―.
Market CapHK$199.61M
Enterprise Value―
Share Statistics
Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding633,693,050
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sinopharm Tech Holdings Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is -90.15%.
Return on Equity (ROE)0.02
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-90.15%
Return on Capital Employed (ROCE)0.43
Revenue Per Employee2.04M
Profits Per Employee-28.90K
Employee Count30
Asset Turnover1.18
Inventory Turnover3.54
Valuation Ratios
The current PE Ratio of Sinopharm Tech Holdings Limited is ―. Sinopharm Tech Holdings Limited’s PEG ratio is 1.01.
PE Ratio―
PS Ratio1.40
PB Ratio-2.33
Price to Fair Value-2.33
Price to FCF-11.93
Price to Operating Cash Flow-15.65
PEG Ratio1.01
Income Statement
In the last 12 months, Sinopharm Tech Holdings Limited had revenue of 61.25M and earned -867.00K in profits. Earnings per share was 0.00.
Revenue61.25M
Gross Profit13.52M
Operating Income-7.13M
Pretax Income-1.08M
Net Income-867.00K
EBITDA6.11M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -5.69M and capital expenditures 4.91M, giving a free cash flow of -781.00K billion.
Operating Cash Flow-5.69M
Free Cash Flow-781.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Sinopharm Tech Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change220.00%
50-Day Moving Average0.26
200-Day Moving Average0.20
Relative Strength Index (RSI)59.63
Average Volume (3m)114.15K
Important Dates
Sinopharm Tech Holdings Limited upcoming earnings date is Nov 12, 2025, TBA (Confirmed).
Last Earnings DateSep 26, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date―
Financial Position
Sinopharm Tech Holdings Limited as a current ratio of 0.72, with Debt / Equity ratio of -126.76%
Current Ratio0.72
Quick Ratio0.52
Debt to Market Cap0.31
Net Debt to EBITDA6.51
Interest Coverage Ratio-1.22
Taxes
In the past 12 months, Sinopharm Tech Holdings Limited has paid 291.00K in taxes.
Income Tax291.00K
Effective Tax Rate-0.27
Enterprise Valuation
Sinopharm Tech Holdings Limited EV to EBITDA ratio is 20.59, with an EV/FCF ratio of -17.45.
EV to Sales2.05
EV to EBITDA20.59
EV to Free Cash Flow-17.45
EV to Operating Cash Flow-17.45
Balance Sheet
Sinopharm Tech Holdings Limited has HK$6.95M in cash and marketable securities with HK$46.73M in debt, giving a net cash position of -HK$39.79M billion.
Cash & Marketable SecuritiesHK$6.95M
Total DebtHK$46.73M
Net Cash-HK$39.79M
Net Cash Per Share-HK$0.06
Tangible Book Value Per Share-HK$0.08
Margins
Gross margin is 19.27%, with operating margin of -11.64%, and net profit margin of -1.42%.
Gross Margin19.27%
Operating Margin-11.64%
Pretax Margin-1.76%
Net Profit Margin-1.42%
EBITDA Margin9.97%
EBIT Margin7.80%
Analyst Forecast
The average price target for Sinopharm Tech Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast48.39%
EPS Growth Forecast88.30%